Laryngorhinootologie 2019; 98(09): 638-650
DOI: 10.1055/a-0901-9863
Facharztwissen HNO
© Georg Thieme Verlag KG Stuttgart · New York

Chirurgische Therapieoptionen bei obstruktiven schlafbezogenen Atmungsstörungen und Schnarchen

Surgical therapy options in obstructive sleep apnoe and snoring
Maren Just
,
Andreas Dietz
Further Information

Publication History

Publication Date:
09 September 2019 (online)

Zusammenfassung

Entsprechend der ICSD-3 wird eine obstruktive Schlafapnoe (OSA) dann diagnostiziert, wenn die Atmungsstörung durch keine andere Schlafstörung oder medizinische Erkrankung oder durch Medikamente oder andere Substanzen erklärbar ist und entweder ein AHI (Apnoe-Hypopnoe-Index-Anzahl der Apnoen und Hypopnoen pro Stunde Schlaf) > 15/h (Ereignis ≥ 10 s) Schlafzeit oder ein AHI ≥ 5/h Schlafzeit in Kombination mit einer typischen klinischen Symptomatik oder relevanten Komorbidität vorliegt [1].

Abstract

The prevalence of mild obstructive sleep apnea (OSA) in adults is 20 %, of moderate to severe OSA about 6–7 %. The current gold standard for the treatment of moderate to severe OSA is the continuous positive airway pressure (CPAP) therapy. It is the most effective treatment modality, if there is good compliance and therapy adherence. Poor adherence still remains a problem for OSA treatment. In contrast to CPAP therapy, surgical therapy offers 100 % therapy adherence. Various surgical procedures are available for the treatment of primary snoring and mild to moderate OSA.

Surgical therapy requires adequate preoperative diagnostics including a good clinical basic ENT examination after detailed sleep medicine anamnesis. Additionally, the drug-induced sleep endoscopy to determine collapse location, collapse pattern and degree of collapse could be performed. According to Sher et al, the surgical success of a therapy in OSA is defined as a reduction of the apnea-hypopnea-index (AHI) by at least half and below a value of 20/h. In contrast, successful CPAP therapy is defined with an AHI below < 5/h but the acceptance, adherence and compliance to CPAP therapy should be always considered too.

In severe OSA, surgical approaches should only be performed to optimize ventilation therapy or in cases of intolerance or lack of adherence.

 
  • Literatur

  • 1 Mayer G, Arzt M, Braumann B. et al. S3- Leitlinie Nicht erholsamer Schlaf/Schlafstörungen, Kapitel „Schlafbezogene Atmungsstörungen bei Erwachsenen“. Im Internet: www.awmf.org/uploads/tx_szleitlinien/063–001l_S3_SBAS_2017–08_2.pdf
  • 2 Wilhelm I, Rose M, Imhof KI. et al. The sleeping child outplays the adult´s capacity to convert implicit into explicit knowledge. Nat Neurosci 2013; 16: 391-393
  • 3 Verse T, Hörmann K. Operative Therapie der Obstruktion bei schlafbezogenen Atemstörungen. Dt. Ärzteblatt 2011; 108 (13) 216-221
  • 4 Zahnert Th. Schlafbezogene Atmungsstörungen. Laryngo- Rhino- Otologie 2011; 90: 691-707
  • 5 Stuck BA. et al. S2k-Leitlinie „Diagnostik und Therapie des Schnarchens des Erwachsenen“. Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/017–068l_S2k_Leitlinie_Schnarchen_2013-verlaengert_01.pdf
  • 6 Pieters T, Collard P, Aubert G. et al. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J 1996; 9: 939-9446
  • 7 Grote L, Hedner J, Grunstein R. et al. Therapy with nCPAP: incomplete elimination of sleep related breathing disorder. Eur Respir J 2000; 16: 921-9277
  • 8 Ravesloot MJL, de Vries N, Stuck BA. Treatment adherence should be taken into account when reporting treatment outcomes in obstructive sleep apnea. Laryngoscope 2014; 124: 344-3458
  • 9 Stuck BA, Leitzbach S, Maurer JT. Effects of continuouspositive airway pressure on apnea-hypopnea index in obstructive sleep apnea based on long-term compliance. Sleep Breath 2010; 16: 467-4719
  • 10 Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996; 19: 156-177
  • 11 Borowieki B, Pollak CP, Weitzman ED. et al. Fibrooptic study of pharyngeal airway during sleep in patients with hypersomnia obstructive sleep- apnoe syndrome. Laryngoscope 1978; 88: 1310-1313
  • 12 De Vita A, Carrasco Llatas M, Ravesloot MJ. et al. European position paper on drug-induced sleep endoscopy: 2017 Update. Clin Otolaryngol 2018; 43: 1541-1552
  • 13 Widmer G, Tschopp K, Kneschke TO. Alternativen zur CPAP- Therapie? Die Schlafendoskopie hilft bei der richtigen Wahl. Swiss Medical Forum 2016; 16 (11) 273-278
  • 14 Kezirian EJ, Hohenhorst W, de Vries N. Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol 2011; 268: 1233-1236
  • 15 Vicini C, De Vito A, Benazzo M. et al. The nose oropharynx hypopharynx and larynx (NOHL) classification: a new system of diagnostic standardized examination for OSAHS patients. Eur ArchOtorhinolaryngol 2012; 269: 1297-1300
  • 16 Eichler C, Sommer JU, Stuck BA. et al. Does drug-induced sleep endoscopy change the treatment concept of patients with snoring and obstructive sleep apnea?. Sleep Breath 2013; 17 (01) 63-8
  • 17 Verse T, Bodlaj R, de la Chaux R. et al. ArGe Schlafmedizin der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. S2e- Leitlinie: HNO- spezifische Therapie der obstruktiven Schlafapnoe bei Erwachsenen. HNO. 09/2015
  • 18 Nelson LM. Temperature-controlled radiofrequency tonsil reduction in children. Arch Otolaryngol Head Neck Surg 2003; 129: 533-7
  • 19 Toh ST, Hsu PP, Ng YH. et al. Incidence of complications after temperature-controlled radiofrequency treatment for sleep-disordered breathing: a Singapore sleep centre experience. J Laryngol Otol 2008; 122: 490-4
  • 20 Maurer JT, Verse T, Stuck BA. et al. Palatal implants for primary snoring: short-term results of a new minimally invasive surgical technique. Oto-laryngol Head Neck Surg 2005; 132: 125-31
  • 21 Ikematsu T. Study of snoring. Therapy. J Jpn Otol Rhinol Laryngol Soc 1964; 64: 434-435
  • 22 Pirsig W, Schäfer J, Yildiz F. et al. Uvulopalatopharyngoplastik ohne Komplikationen: eine Modifikation nach Fujita. Laryngorhinootologie 1989; 68: 585-590
  • 23 Sommer JU, Heiser C, Gahleitner C. et al. Tonsillectomy with uvulopalatopharyngoplasty in obstructive sleep apnoe- a two center randomized controlled trail. Dtsch Arztebl Int 2016; 113: 1-8
  • 24 Browaldh N, Nerfeldt P, Lysdahl M. et al. SKUP3 randomised controlled trial: polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnoea. Thorax 2013; 68: 846-53
  • 25 Stuck BA, Ravesloot MJ, Eschenhagen T. et al. Tonsillektomie mit Uvulopalatopharyngoplastik zur Behandlung der obstruktiven Schlafapnoe des erwachsenen. Ein systematischer Review in der Kurzfassung. Somnologie 2018; 02
  • 26 Maurer JT. Update on surgical treatments for sleep apnea. Swiss Med Wkly 2009; 139: 624-629
  • 27 Heiser C, Hofauer B. Hypoglossusnervstimulation bei CPAP-Versagen. HNO 2017; 65: 99-106
  • 28 Heiser C. et al. Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry. Eur Respir J 2019; 53: 1801405
  • 29 Conradt R, Hochban W, Heitmann J. et al. Sleep fragmentation and daytime vigilance in patients with OSA treated by surgical maxillomandibular advancement compared to CPAP therapy. J Sleep Res 1998; 7: 217-23